{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Functionality Summary\n",
    "In this notebook, we did\n",
    "* Baseline experiments for NB (with vectors created from TFIDF)\n",
    "* built the whole vocabulary on the RFA and testing on publications belonging to the test data\n",
    "* vector representations were chosen based on best-performing on train/validation\n",
    "* all evaluations are done on the test datasets "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pickle\n",
    "import os\n",
    "import sys\n",
    "import argparse \n",
    "import ast\n",
    "import pandas as pd\n",
    "import numpy as np\n",
    "import logging \n",
    "from sklearn.feature_extraction.text import TfidfVectorizer\n",
    "from sklearn.metrics.pairwise import linear_kernel\n",
    "from sklearn.naive_bayes import MultinomialNB\n",
    "from sklearn.pipeline import make_pipeline, Pipeline\n",
    "from sklearn.base import BaseEstimator, TransformerMixin\n",
    "from sklearn.preprocessing import OneHotEncoder, StandardScaler, FunctionTransformer\n",
    "from sklearn.impute import SimpleImputer\n",
    "from sklearn.pipeline import FeatureUnion, Pipeline\n",
    "#from sklearn import cross_validation\n",
    "# from sklearn.model_selection import RandomizedSearchCV\n",
    "from scipy import sparse\n",
    "from scipy.sparse import hstack\n",
    "from sklearn.metrics import accuracy_score, roc_curve, auc\n",
    "\n",
    "#local \n",
    "import utils_bsl as ut"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [],
   "source": [
    "#in the order that they will be used\n",
    "parser = argparse.ArgumentParser(description = 'NB classifier (with tfidf) for Grant recommendation')\n",
    "parser.add_argument('-data_path', type = str, default = 'newdata/', \n",
    "                    help = 'complete path to the training data [default:newdata/]')\n",
    "parser.add_argument('-load_pretrained', type = bool, default = False,\n",
    "                    help = 'whether to load pretrained NB related vectors/models [default:False]')\n",
    "parser.add_argument('-load_path', type = str, default = 'evalAuto/nb/', \n",
    "                    help = 'path where nb related vectors/models are saved [default:evalAuto/nb/]')\n",
    "# some training parameters regarding NB \n",
    "parser.add_argument('-ngram_range', type = str, default = '(1,2)', help = 'see sklearn TFIDF params')\n",
    "parser.add_argument('-min_df', type = int, default = 2, help = 'see sklearn TFIDF params')\n",
    "parser.add_argument('-max_features', type = int, default = 2000, help = 'see sklearn TFIDF params')\n",
    "parser.add_argument('-alpha', type = int, default = 0.5, help = 'see sklearn NB params')\n",
    "parser.add_argument('-top', type = int, default = 10, \n",
    "                    help = 'number of recommendations to take [default:10]')\n",
    "args = parser.parse_args([])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [],
   "source": [
    "def main(args):\n",
    "    seed_val = 1234\n",
    "    ut.set_seed(seed_val) \n",
    "    \n",
    "    # get logger started\n",
    "    logging.basicConfig(level=logging.ERROR, filename= args.load_path + \"logfile\", filemode=\"a+\",\n",
    "                            format=\"%(asctime)-15s %(levelname)-8s %(message)s\")\n",
    "    logger = logging.getLogger('NB for grant')\n",
    "    handler = logging.FileHandler(args.load_path + \"logfile\")\n",
    "    logger.addHandler(handler)\n",
    "    logger.error('NB for grant')\n",
    "    \n",
    "    try:\n",
    "        nb = Pipeline(steps =[('vectorizer', TfidfVectorizer(ngram_range = ast.literal_eval(args.ngram_range), \n",
    "                                                             min_df = args.min_df,\n",
    "                                                             max_features = args.max_features)), \n",
    "                              ('mnb', MultinomialNB(alpha = args.alpha))])\n",
    "        # train, valid and test \n",
    "        rfas, pubs, mix_df, \\\n",
    "        train_idx, valid_idx, test_idx, \\\n",
    "        train_citation, valid_citation, citation, \\\n",
    "        train_mixed, valid_mixed, test_mixed = ut.load_data(args.data_path)\n",
    "\n",
    "        train_X, train_y, train_pmids, train_rfaids = ut.select_data_nb(idx = train_idx, mix_df = mix_df, \\\n",
    "                                                                        pubs = pubs, rfas = rfas,\\\n",
    "                                                                        outpath = args.load_path, idx_name = 'train_',\\\n",
    "                                                                        load_pretrained = args.load_pretrained)\n",
    "        valid_X, valid_y, valid_pmids, valid_rfaids = ut.select_data_nb(idx = valid_idx, mix_df = mix_df, \\\n",
    "                                                                        pubs = pubs, rfas = rfas,\\\n",
    "                                                                        outpath = args.load_path, idx_name = 'valid_',\\\n",
    "                                                                        load_pretrained = args.load_pretrained)\n",
    "        test_X, test_y, test_pmids, test_rfaids = ut.select_data_nb(idx = test_idx, mix_df = mix_df,\\\n",
    "                                                                    pubs = pubs, rfas = rfas,\\\n",
    "                                                                    outpath = args.load_path, idx_name = 'test_',\\\n",
    "                                                                    load_pretrained = args.load_pretrained)\n",
    "\n",
    "        # train and predic\n",
    "        nb.fit(train_X, train_y)\n",
    "        train_y_probas  = nb.predict_proba(train_X)\n",
    "        valid_y_probas  = nb.predict_proba(valid_X)\n",
    "        test_y_probas  = nb.predict_proba(test_X)\n",
    "        \n",
    "        train_dict, _ = ut.create_smilarity_dict(pmids = train_pmids, rfaids = train_rfaids, \n",
    "                                             combine_predictions_probas = train_y_probas, \\\n",
    "                                             save_path = args.load_path, idx_name = 'train_')\n",
    "        valid_dict, _ = ut.create_smilarity_dict(pmids = valid_pmids, rfaids = valid_rfaids, \n",
    "                                             combine_predictions_probas = valid_y_probas, \\\n",
    "                                             save_path = args.load_path, idx_name = 'valid_')\n",
    "        test_dict, _ = ut.create_smilarity_dict(pmids = test_pmids, rfaids = test_rfaids, \n",
    "                                             combine_predictions_probas = test_y_probas, \\\n",
    "                                             save_path = args.load_path, idx_name = 'test_')\n",
    "        # evaluation on train and test \n",
    "        logger.error('=======train statistics======')\n",
    "        train_auc = ut.mini_auc(train_y, train_y_probas)\n",
    "        logger.error('train auc = {}'.format(train_auc))\n",
    "        ut.print_metrics(citation = train_citation, similarity_dict = train_dict, logger = logger, ks = [1, 5])\n",
    "        print('=========================================')\n",
    "        logger.error('=======test statistics======')\n",
    "        test_auc = ut.mini_auc(test_y, test_y_probas)\n",
    "        logger.error('test auc = {}'.format(test_auc))\n",
    "        ut.print_metrics(citation = citation, similarity_dict = test_dict, logger = logger, ks = [1, 5])\n",
    "        logging.shutdown()\n",
    "        for handler in logger.handlers:\n",
    "            if isinstance(handler, logging.FileHandler):\n",
    "                handler.close()\n",
    "                \n",
    "    except KeyboardInterrupt:\n",
    "        print(colored('--' * 70, 'green'))\n",
    "        print(colored('Exiting from training early', 'green'))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {
    "scrolled": false
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "length of the corpus 310092\n",
      "sample of the corpus ['clinical response dorsal duct drainage via minor papilla refractory obstruct chronic calcific pancreatitis background study aim complete stone removal main pancreatic duct might achieve patient obstructive chronic calcific pancreatitis report result endoscopic dorsal pancreatic duct dpd bypass obstruct stone ventral pancreatic duct vpd patient method patient obstructive chronic calcific pancreatitis treat dpd bypass clinical success define significant pain relief hospital admission pain management ongoing treatment period result among patient meet entry criterion 62.5 history unsuccessful endoscopic therapy fail extracorporeal shockwave lithotripsy eswl clinical success achieve patient among responder patient 83.3 markedly improve complete pain relief first stent placement persist throughout follow-up period patient 91.7 able discontinue daily analgesic conclusion select patient obstructive chronic calcific pancreatitis dpd bypass consider rescue endoscopic therapy potentially obviate need surgery standard endoscopic method eswl fail', 'vivo-activated mononuclear phagocyte protective immunity chlamydiae mouse peritoneal macrophage phi collect chlamydia psittaci 6bc-immune mouse intraperitoneal challenge 6bc immune-boosted ib phi compare various functional criterion vivo- vitro-activated phi population casein- protease peptone- thioglycolate thio -elicited phi equally susceptible vitro infection 6bc ib phi support chlamydial growth phi mycobacterium tuberculosis bcg- listeria monocytogenes-sensitized mouse exhibit intermediate susceptibility infection resistance ib phi due ingestion 6bc organism cell persistently infect since chlamydiae recover infect ib phi vitro infection even extend incubation time contrast thio phi stimulate vitro gamma interferon ifn-gamma without lipopolysaccharide result cell exhibit chlamydiastatic activity lose shortly ifn-gamma remove culture medium conversely antichlamydial activity ib phi stable time production autostimulatory cytokine evidence lack stimulation thio phi restrict 6bc replication coculture experiment ib phi exhibit enhanced oxidative activity anti-ifn-gamma antibody abrogate response ib phi recover immunize mouse survive otherwise lethal 6bc intraperitoneal challenge cell appear important development protective immunity chlamydiae evidence suggest stimulation cytokine ifn-gamma without lipopolysaccharide require observed heighten vivo activation']\n",
      "length of the corpus 310092\n",
      "sample of the corpus ['diabetes research training behavioral scientist t32 foster development diverse highly trained workforce behavioral scientist assume leadership role relate nation research effort area type diabetes national institute diabetes digestive kidney disease niddk national institute nursing research ninr invite application establishment institutional research training program develop cadre diverse highly trained behavioral scientist conduct research relevant improve clinical management quality life patient type diabetes.training grant t32 award make eligible institution provide program prepare predoctoral postdoctoral behavioral scientist select institution behavioral research career type diabetes stage training supervision mentorship include diabetologist behavioral scientist way maximize relevance training type diabetes encourage multi-disciplinary approach research', 'novel innovative tool facilitate identification track manipulation analysis glycans function r21 common fund program accelerate translation glycoscience integration accessibility- aim develop accessible affordable new tool technology study carbohydrate enable researcher biomedical field dramatically advance understanding role complex molecule health disease abandon glycan discovery due difficulty inability study foa solicit development new easily accessible tool reagent technology facilitate identification track manipulation analysis glycans biological binding partner determine function initiative build effort interface exist technology procedure make easy access use applicable effort must consider factor scale-up effort make instrumentation broadly accessible cost-effective end-user compatibility data generate integration exist database']\n",
      "length of the corpus 310092\n",
      "sample of the corpus ['clinical response dorsal duct drainage via minor papilla refractory obstruct chronic calcific pancreatitis background study aim complete stone removal main pancreatic duct might achieve patient obstructive chronic calcific pancreatitis report result endoscopic dorsal pancreatic duct dpd bypass obstruct stone ventral pancreatic duct vpd patient method patient obstructive chronic calcific pancreatitis treat dpd bypass clinical success define significant pain relief hospital admission pain management ongoing treatment period result among patient meet entry criterion 62.5 history unsuccessful endoscopic therapy fail extracorporeal shockwave lithotripsy eswl clinical success achieve patient among responder patient 83.3 markedly improve complete pain relief first stent placement persist throughout follow-up period patient 91.7 able discontinue daily analgesic conclusion select patient obstructive chronic calcific pancreatitis dpd bypass consider rescue endoscopic therapy potentially obviate need surgery standard endoscopic method eswl fail', 'vivo-activated mononuclear phagocyte protective immunity chlamydiae mouse peritoneal macrophage phi collect chlamydia psittaci 6bc-immune mouse intraperitoneal challenge 6bc immune-boosted ib phi compare various functional criterion vivo- vitro-activated phi population casein- protease peptone- thioglycolate thio -elicited phi equally susceptible vitro infection 6bc ib phi support chlamydial growth phi mycobacterium tuberculosis bcg- listeria monocytogenes-sensitized mouse exhibit intermediate susceptibility infection resistance ib phi due ingestion 6bc organism cell persistently infect since chlamydiae recover infect ib phi vitro infection even extend incubation time contrast thio phi stimulate vitro gamma interferon ifn-gamma without lipopolysaccharide result cell exhibit chlamydiastatic activity lose shortly ifn-gamma remove culture medium conversely antichlamydial activity ib phi stable time production autostimulatory cytokine evidence lack stimulation thio phi restrict 6bc replication coculture experiment ib phi exhibit enhanced oxidative activity anti-ifn-gamma antibody abrogate response ib phi recover immunize mouse survive otherwise lethal 6bc intraperitoneal challenge cell appear important development protective immunity chlamydiae evidence suggest stimulation cytokine ifn-gamma without lipopolysaccharide require observed heighten vivo activation']\n",
      "length of the corpus 310092\n",
      "sample of the corpus ['diabetes research training behavioral scientist t32 foster development diverse highly trained workforce behavioral scientist assume leadership role relate nation research effort area type diabetes national institute diabetes digestive kidney disease niddk national institute nursing research ninr invite application establishment institutional research training program develop cadre diverse highly trained behavioral scientist conduct research relevant improve clinical management quality life patient type diabetes.training grant t32 award make eligible institution provide program prepare predoctoral postdoctoral behavioral scientist select institution behavioral research career type diabetes stage training supervision mentorship include diabetologist behavioral scientist way maximize relevance training type diabetes encourage multi-disciplinary approach research', 'novel innovative tool facilitate identification track manipulation analysis glycans function r21 common fund program accelerate translation glycoscience integration accessibility- aim develop accessible affordable new tool technology study carbohydrate enable researcher biomedical field dramatically advance understanding role complex molecule health disease abandon glycan discovery due difficulty inability study foa solicit development new easily accessible tool reagent technology facilitate identification track manipulation analysis glycans biological binding partner determine function initiative build effort interface exist technology procedure make easy access use applicable effort must consider factor scale-up effort make instrumentation broadly accessible cost-effective end-user compatibility data generate integration exist database']\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "length of the corpus 310092\n",
      "sample of the corpus ['clinical response dorsal duct drainage via minor papilla refractory obstruct chronic calcific pancreatitis background study aim complete stone removal main pancreatic duct might achieve patient obstructive chronic calcific pancreatitis report result endoscopic dorsal pancreatic duct dpd bypass obstruct stone ventral pancreatic duct vpd patient method patient obstructive chronic calcific pancreatitis treat dpd bypass clinical success define significant pain relief hospital admission pain management ongoing treatment period result among patient meet entry criterion 62.5 history unsuccessful endoscopic therapy fail extracorporeal shockwave lithotripsy eswl clinical success achieve patient among responder patient 83.3 markedly improve complete pain relief first stent placement persist throughout follow-up period patient 91.7 able discontinue daily analgesic conclusion select patient obstructive chronic calcific pancreatitis dpd bypass consider rescue endoscopic therapy potentially obviate need surgery standard endoscopic method eswl fail', 'vivo-activated mononuclear phagocyte protective immunity chlamydiae mouse peritoneal macrophage phi collect chlamydia psittaci 6bc-immune mouse intraperitoneal challenge 6bc immune-boosted ib phi compare various functional criterion vivo- vitro-activated phi population casein- protease peptone- thioglycolate thio -elicited phi equally susceptible vitro infection 6bc ib phi support chlamydial growth phi mycobacterium tuberculosis bcg- listeria monocytogenes-sensitized mouse exhibit intermediate susceptibility infection resistance ib phi due ingestion 6bc organism cell persistently infect since chlamydiae recover infect ib phi vitro infection even extend incubation time contrast thio phi stimulate vitro gamma interferon ifn-gamma without lipopolysaccharide result cell exhibit chlamydiastatic activity lose shortly ifn-gamma remove culture medium conversely antichlamydial activity ib phi stable time production autostimulatory cytokine evidence lack stimulation thio phi restrict 6bc replication coculture experiment ib phi exhibit enhanced oxidative activity anti-ifn-gamma antibody abrogate response ib phi recover immunize mouse survive otherwise lethal 6bc intraperitoneal challenge cell appear important development protective immunity chlamydiae evidence suggest stimulation cytokine ifn-gamma without lipopolysaccharide require observed heighten vivo activation']\n",
      "length of the corpus 310092\n",
      "sample of the corpus ['diabetes research training behavioral scientist t32 foster development diverse highly trained workforce behavioral scientist assume leadership role relate nation research effort area type diabetes national institute diabetes digestive kidney disease niddk national institute nursing research ninr invite application establishment institutional research training program develop cadre diverse highly trained behavioral scientist conduct research relevant improve clinical management quality life patient type diabetes.training grant t32 award make eligible institution provide program prepare predoctoral postdoctoral behavioral scientist select institution behavioral research career type diabetes stage training supervision mentorship include diabetologist behavioral scientist way maximize relevance training type diabetes encourage multi-disciplinary approach research', 'novel innovative tool facilitate identification track manipulation analysis glycans function r21 common fund program accelerate translation glycoscience integration accessibility- aim develop accessible affordable new tool technology study carbohydrate enable researcher biomedical field dramatically advance understanding role complex molecule health disease abandon glycan discovery due difficulty inability study foa solicit development new easily accessible tool reagent technology facilitate identification track manipulation analysis glycans biological binding partner determine function initiative build effort interface exist technology procedure make easy access use applicable effort must consider factor scale-up effort make instrumentation broadly accessible cost-effective end-user compatibility data generate integration exist database']\n",
      "(45240, 3)\n",
      "      pmid                rfas_recom                                 rfas_prob\n",
      "0  1280376              [PAR-10-285]                      [0.9642564870210485]\n",
      "1  1281463  [PAR-10-223, PAR-14-232]  [0.9680324476720235, 0.9437040851297536]\n",
      "2  1282437              [PAR-13-386]                      [0.9999999999964473]\n",
      "3  1288367              [PAR-11-066]                      [0.8543420983656124]\n",
      "4  1292778               [PA-10-036]                      [0.9978304643485542]\n",
      "5\n",
      "(5919, 3)\n",
      "      pmid                rfas_recom                                 rfas_prob\n",
      "0  1311716              [PAR-10-285]                      [0.8370678397376904]\n",
      "1  1314536               [PA-10-036]                      [0.9936503620175717]\n",
      "2  1325854  [PAR-12-005, PAR-18-290]  [0.9993295766247108, 0.9990328592487314]\n",
      "3  1334205              [PAR-08-259]                      [0.5548430618734617]\n",
      "4  1356515              [PAR-13-386]                      [0.9999999993224549]\n",
      "4\n",
      "(13749, 3)\n",
      "      pmid                rfas_recom                                 rfas_prob\n",
      "0  1286572               [PA-08-227]                      [0.9403609396508185]\n",
      "1  1287764  [PAR-17-095, PAR-12-298]  [0.9999999999999147, 0.9999999999998437]\n",
      "2  1306884  [PAR-12-298, PAR-17-095]  [0.9999999999958078, 0.9999999999970299]\n",
      "3  1309259  [PAR-12-298, PAR-17-095]  [0.9999999997569375, 0.9999999997834408]\n",
      "4  1310173              [PAR-13-316]                      [0.8785608648395968]\n",
      "5\n",
      "MRR:\n",
      "0.9170154076525989\n",
      "recall@1, recall@5:\n",
      "0.7353824329116917\n",
      "0.791204634117508\n",
      "precision@1, precision@5:\n",
      "0.8639082633881073\n",
      "0.7928514008748079\n",
      "MAP:\n",
      "0.9170154076525989\n",
      "=========================================\n",
      "MRR:\n",
      "0.9188960819488861\n",
      "recall@1, recall@5:\n",
      "0.7381249512518524\n",
      "0.7912409328445519\n",
      "precision@1, precision@5:\n",
      "0.8682630060057718\n",
      "0.7921144996490134\n",
      "MAP:\n",
      "0.9188960819488861\n"
     ]
    }
   ],
   "source": [
    "if __name__ == \"__main__\":\n",
    "    main(args)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.11"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
